Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
Thanks to a multiyear strategy supported by LHSS and predecessor USAID projects, Vietnam now funds approximately 52 percent of its HIV/AIDS program through domestic financial resources.
Through intensive engagement with residents, health workers and other community leaders countered misinformation and eased people's concerns. The result: thousands more COVID-19 vaccinations.
2022 marked Vietnam's 10-year journey to sustain its HIV response with domestic financing (2013 – 2022). The country now stands out as a global example for sustainability and domestic resource mobilization for its HIV program.
The Vietnam government transitions funding of TB treatment to the SHI fund with support from LHSS. This transition marks a critical milestone, ensuring uninterrupted access to life-saving treatment.
LHSS features four poster presentations at 24th International AIDS Conference.
This fact sheet provides a summary of activity progress in Central Asia as well as results and impact.
Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO). On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.
This report presents findings from LHSS Vietnam's international review of diagnosis-related group contracts and provides a series of evaluations and recommendations.
This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.
This report provides a review of international experience to draw out practical and scientific approaches for both the Ministry of Health (MOH) and Vietnam Social Security (VSS) to consider. Conclusions and recommendations are provided.
Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.
Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.
Accurate and timely identification of COVID-19 variants in circulation is critical to an effective COVID-19 response. Following the delivery of parts and equipment to refurbish the country’s only COVID-19 specific genomic sequencing machine, LHSS supported training for laboratory specialists on genomic sequencing of COVID-19 virus variants.
This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.
This report summarizes the results of a review of international experience and best practices related to pro-health excise taxes.